Large-scale testing (Phase 3)UnknownNCT05802342
What this trial is testing
A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
Who this might be right for
To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
Qilu Pharmaceutical Co., Ltd. 150